Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

RLS Global AB (publ)

RLS.ST

HealthcareSTOSE

SEK 0.446

-SEK 0.004 (-0.89%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

RLS.ST

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.446H 0.446L 0.446C 0.446Date Nov 21

RLS.ST

SMA 20 SMA 50 Vol 0

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

RLS Global AB (publ) is a Swedish medical technology firm that specializes in developing and commercializing therapeutic products for conditions within wound and oral care. Among its key offerings are ChloraSolv, a treatment specifically designed for chronic diabetic foot and leg ulcers in diabetic patients, and CariSolv, a unique gel employed for the removal of dental caries. Established in 1996, the company maintains its headquarters in Mölndal, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$35.70M

Volume?7.21K

Avg Volume?698

52w RangeSEK 0.446 - SEK 0.446

Beta?0.57

Price Performance

No historical price data is available for this symbol yet.

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide